uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted May 13, 2015

Amberen Weight Loss Claims Not Supported by Evidence, Says FTC

On May 12, 2015, the FTC announced it filed a complaint to stop Lunada Biomedical Inc. from advertising that its product Amberen is clinically proven to cause substantial weight loss in women over 40.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at